{"id":1651,"date":"2020-10-30T12:13:28","date_gmt":"2020-10-30T11:13:28","guid":{"rendered":"https:\/\/www.cscorporateadvisors.com\/?post_type=portfolio&#038;p=1651"},"modified":"2021-06-04T10:50:11","modified_gmt":"2021-06-04T08:50:11","slug":"devicare-2020","status":"publish","type":"portfolio","link":"https:\/\/cscorporateadvisors.com\/en\/transacciones\/devicare-2020\/","title":{"rendered":"Devicare 2020 ENG"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row row_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243;][vc_column width=&#8221;1\/3&#8243;][vc_single_image media=&#8221;2082&#8243; media_width_percent=&#8221;100&#8243; border=&#8221;yes&#8221; shadow=&#8221;yes&#8221; shadow_weight=&#8221;sm&#8221;][\/vc_column][vc_column width=&#8221;2\/3&#8243;][vc_custom_heading auto_text=&#8221;yes&#8221; heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; text_color=&#8221;color-825618&#8243;]This is a custom heading element.[\/vc_custom_heading][vc_column_text]<\/p>\n<p style=\"font-weight: 400;\"><strong>CS\u00a0Corporate\u00a0Advisors<\/strong><strong>\u00a0<\/strong>has acted as advisor to\u00a0<strong>Devicare<\/strong>\u00a0on the search and contribution of private investor to complete its funding round for a total amount of \u20ac3 M.<\/p>\n<p style=\"font-weight: 400;\"><strong>Devicare<\/strong>\u00a0is a company located in Barcelona specialized in the development, manufacture and remote management of innovative medical devices for home care of chronic patients.<\/p>\n<p>&nbsp;<\/p>\n<p style=\"font-weight: 400;\">The financing round started in 2016 with the entrance of the investment holding\u00a0<strong>EMESA<\/strong>\u00a0<strong>Corporaci\u00f3n Empresarial<\/strong>\u00a0(family office of the recognized lawer\u00a0<strong>Emilio Cuatrecasas<\/strong>) and\u00a0<strong>Caixa Capital Risc<\/strong>. Different family offices and\u00a0corporate\u00a0partners were later incorporated, such as Mr. Juan Knuth (<strong>Palex Medical<\/strong>), the Gaya family (<strong>Eladiet<\/strong>), the Xiol family (<strong>Peroxfarma<\/strong>), the Serra family (<strong>Boyser<\/strong>), among others, in addition to the employees of the company.<\/p>\n<p>&nbsp;<\/p>\n<p style=\"font-weight: 400;\">This funding will be used to consolidate the launch of clinical studies of two of\u00a0Devicare\u00b4s main product lines on the Spanish market: Lit-Control\u00ae\u00a0for prevention and self-management of recurring urinary diseases ant Tao-Control\u00ae\u00a0for self-management of patients who take care oral anticoagulants (Sintrom\u00ae, Aldocumar\u00ae, etc).<\/p>\n<p>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row row_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243;][vc_column width=&#8221;1\/3&#8243;][vc_single_image media=&#8221;2082&#8243; media_width_percent=&#8221;100&#8243; border=&#8221;yes&#8221; shadow=&#8221;yes&#8221; shadow_weight=&#8221;sm&#8221;][\/vc_column][vc_column width=&#8221;2\/3&#8243;][vc_custom_heading auto_text=&#8221;yes&#8221; heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; text_color=&#8221;color-825618&#8243;]This is a [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":2078,"parent":0,"menu_order":1,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"portfolio_category":[],"class_list":["post-1651","portfolio","type-portfolio","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/cscorporateadvisors.com\/en\/wp-json\/wp\/v2\/portfolio\/1651","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cscorporateadvisors.com\/en\/wp-json\/wp\/v2\/portfolio"}],"about":[{"href":"https:\/\/cscorporateadvisors.com\/en\/wp-json\/wp\/v2\/types\/portfolio"}],"author":[{"embeddable":true,"href":"https:\/\/cscorporateadvisors.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cscorporateadvisors.com\/en\/wp-json\/wp\/v2\/comments?post=1651"}],"version-history":[{"count":4,"href":"https:\/\/cscorporateadvisors.com\/en\/wp-json\/wp\/v2\/portfolio\/1651\/revisions"}],"predecessor-version":[{"id":2084,"href":"https:\/\/cscorporateadvisors.com\/en\/wp-json\/wp\/v2\/portfolio\/1651\/revisions\/2084"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cscorporateadvisors.com\/en\/wp-json\/wp\/v2\/media\/2078"}],"wp:attachment":[{"href":"https:\/\/cscorporateadvisors.com\/en\/wp-json\/wp\/v2\/media?parent=1651"}],"wp:term":[{"taxonomy":"portfolio_category","embeddable":true,"href":"https:\/\/cscorporateadvisors.com\/en\/wp-json\/wp\/v2\/portfolio_category?post=1651"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}